Cleft palate (CP) is the most prevalent craniofacial deformity, with ethnic and geographic variation in prevalence in humans. Mice have been used as an animal model to study the cause(s) of CP by several approaches, including genetic and chemical-induced approaches. Mouse genetic approaches revealed that significant amounts of genes are involved in the CP pathology. The aim of this study was to identify common features of CP-associated genes and to explore the roles of microRNAs (miRNAs) as important post-transcriptional regulators that may be involved in the regulation of CP genes. To generate an accurate list of genes associated with CP, we first conducted systematic literature searches through main databases such as Medline, Embase, and PubMed, as well as other sources such as Scopus and Mouse Genome Informatics. We found that 195 mouse strains with single-gene mutations and 140 mouse strains with compound-gene mutations were reported to have CP. The CP genes were categorized by functions and pathways using the Kyoto Encyclopedia of Genes and Genomes and Gene Ontology annotations, highlighting the contribution of cellular metabolism to CP. A total of 18 miRNAs were involved in the regulation of multiple CP genes. Human genotype-phenotype analysis revealed that variants in five human homologous CP genes (IRF6, FOXE1, VAX1, WNT9B, and GAD1) significantly contributed to the human CP phenotype. Thus, our results suggest that cellular metabolism and miRNAs play an important role in the regulation of genetic pathways and networks crucial for palatal formation.
Introduction
Cleft palate (CP) is among the most common human birth defects. It occurs approximately in one in 2000 live births in the U.S., with ethnic and geographic variation in prevalence (Murray, 2002) . CP can appear in both syndromic and nonsyndromic cases with various degrees of phenotypic severity (complete or partial CP [e.g. submucous CP, cleft soft palate]) (Lan et al., 2015) . Individuals with CP require multidisciplinary care from birth through adulthood, including maxillofacial surgery, speech therapy, and dental treatments (Iwata et al., 2011) . Genetic studies in humans and mice, as well as epidemiological studies, have identified a wide array of genetic and environmental risk factors for CP (Dixon et al., 2011; Leslie and Marazita, 2013) . However, its etiology is not yet fully understood because of the complexity of genetic and environmental risk factors as well as gene-environment interactions. In addition, its complexity also derives from nonsyndromic cases, which can be sporadic or inherited as an autosomal dominant trait (Stanier and Moore, 2004) .
The mouse as an animal model is well established and one of the most frequently used models to study the mechanism(s) of craniofacial development. This can be attributed to the facts that: 1) mouse palate development simulates that of humans', with a well-conserved molecular mechanism; 2) genetic background is homogenous; 3) environmental factors are under control; and 4) experimental time needed for their generation and analysis is measurable and short. Although mouse studies have identified significant amounts of CP-associated genes and signaling cascades, it remains unclear how these molecules and signaling pathways interact during palate formation.
Palatal development starts at the sixth week of gestation in humans and at embryonic day 11.5 (E11.5) in mice. The palatal shelves are composed of the mesenchyme derived from cranial neural crest cells (N95%)
